Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Structure-function relationships for the interleukin 2 receptor: location of ligand and antibody binding sites on the Tac receptor chain by mutational analysis.

Robb RJ, Rusk CM, Neeper MP.

Proc Natl Acad Sci U S A. 1988 Aug;85(15):5654-8. Erratum in: Proc Natl Acad Sci U S A 1988 Nov;85(21):8226.

3.
4.

Sequence requirements for ligand binding and cell surface expression of the Tac antigen, a human interleukin-2 receptor.

Cullen BR, Podlaski FJ, Peffer NJ, Hosking JB, Greene WC.

J Biol Chem. 1988 Apr 5;263(10):4900-6.

6.
7.

Direct activation of human resting T cells by IL 2: the role of an IL 2 receptor distinct from the Tac protein.

Bich-Thuy LT, Dukovich M, Peffer NJ, Fauci AS, Kehrl JH, Greene WC.

J Immunol. 1987 Sep 1;139(5):1550-6.

PMID:
3040856
9.

A second human interleukin-2 binding protein that may be a component of high-affinity interleukin-2 receptors.

Dukovich M, Wano Y, Le thi Bich Thuy, Katz P, Cullen BR, Kehrl JH, Greene WC.

Nature. 1987 Jun 11-17;327(6122):518-22.

PMID:
3108674
10.

Analysis of dynamics and functions of high-affinity interleukin-2 receptors.

Gullberg M.

Mol Immunol. 1987 Dec;24(12):1365-71.

PMID:
2828931
11.

[Expression of functional human interleukin 2 receptor in mouse cells by using gene transfection].

Hatakeyama M.

Hokkaido Igaku Zasshi. 1986 Sep;61(5):697-708. Japanese.

PMID:
3096855
12.
13.
15.

Increased binding of IL-2 and increased IL-2 receptor mRNA synthesis are expressed by an NK-like cell line in response to IL-1.

Lubinski J, Fong TC, Babbitt JT, Ransone L, Yodoi JJ, Bloom ET.

J Immunol. 1988 Mar 15;140(6):1903-9.

PMID:
2831272
16.

Only high-affinity receptors for interleukin 2 mediate internalization of ligand.

Weissman AM, Harford JB, Svetlik PB, Leonard WL, Depper JM, Waldmann TA, Greene WC, Klausner RD.

Proc Natl Acad Sci U S A. 1986 Mar;83(5):1463-6.

17.
18.
19.

IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.

Phillips KE, Herring B, Wilson LA, Rickford MS, Zhang M, Goldman CK, Tso JY, Waldmann TA.

Cancer Res. 2000 Dec 15;60(24):6977-84.

Supplemental Content

Support Center